The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LivePerson, Inc. (“LivePerson” or “the Company”) (NASDAQ: LPSN) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. LivePerson announced its fourth quarter 2022 financial results on March 15, 2023, revealing a revenue decline and loss for the quarter. The Company disclosed that its WildHealth subsidiary had received a notice from Medicare that its reimbursement for services under the Medicare demonstrate program (the “Program”) would be suspended. The Company stated, “inherent uncertainty as to the timing and amount of further reimbursement for services rendered under the Program, the Company has elected to take a reserve for revenue associated with services delivered under the Program in the fourth quarter of 2022 for which payment has not yet been collected.” Based on this news, shares of LivePerson dropped by more than 49% in intraday trading on March 16, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230317005073/en/